HCC treatment algorithm with systemic therapy based on the recently updated HCC guidelines
HCC treatment algorithm with systemic therapy based on the recently updated HCC guidelines
Assoc. Prof. Aiwu Ruth He, Assoc. Prof. Matthias Pinter
Professor He and Professor Pinter, discuss their perspectives and experience on how to select systemic therapy options in first line and beyond for patients with advanced or unresectable HCC based on the current international HCC guidelines.
Assoc. Prof. Aiwu Ruth He
Medical Oncologist
Georgetown University School of Medicine
United States (US)
Assoc. Prof. Matthias Pinter
Hepatologist
Medical University of Vienna
Austria
| 
30 min
|
Nov 2021
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Insights from Professor He and Professor Pinter on the international HCC guidelines including NCCN, ASCO, ESMO, ILCA, AASLD and EASL which were revised in late 2020 and in 2021 to include atezolizumab+bevacizumab immunotherapy combination as the new standard of care in first line setting for patients with advanced or unresectable HCC. They discuss which guidelines they follow in their clinical practice and mainly how to select the first systemic therapy option for patients with advanced or unresectable HCC. An Infographic is also available proposing an algorithm providing the criteria to select between lenvatinib and sorafenib in 1L for patients not eligible for atezolizumab+bevacizumab and propose the treatment option sequencing for 2L and beyond after atezolizumab+bevacizumab for patients with advanced or unresectable HCC.
HCC CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer and from Eisai Europe Limited.
Other programmes of interest
28 min
Other programmes developed by Assoc. Prof. Aiwu Ruth He
Assoc. Prof. Aiwu Ruth He
Medical Oncologist
Georgetown University School of Medicine
United States (US)
